Get Yahoo! Toolbar - Protect your PC
Yahoo!
My Yahoo!
Mail
Search
Search
Sign In
New User?
Sign Up
Finance Home
-
Help
Finance Home
Business News
India Business
World Business
RSS Feeds
Investing
Stocks
Currency
Mutual Funds
Personal Finance
Mutual Funds
Taxes
Insurance
Loans
NRI Corner
My Portfolios
Portfolio Manager
Transaction Manager
Sign In to Create/Edit My Portfolios
Get Quotes:
Get Quotes
Wed, Feb 10, 2010, 11:43AM IST
Home
>
Investing
>
JAZZ
> Summary
More on JAZZ
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Jazz Pharmaceuticals, Inc.
(JAZZ)
9.18
USD
0.05
(0.55%)
At
2:30AM IST
Jazz Pharmaceuticals, Inc.
(NGM:JAZZ) Delayed quote data
1d
5d
3m
6m
1y
2y
5y
Last Trade:
9.18
USD
Trade Time:
2:30AM IST
Change:
0.05
(0.55%)
Prev Close:
9.13
Open:
9.26
Bid:
8.38
x
100
Ask:
9.65
x
600
1y Target Est:
10.00
Day's Range:
9.15
-
9.45
52wk Range:
0.52 - 11.88
Volume:
72,043
Avg Vol
(3m)
:
349,919
Market Cap:
284.51M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-2.38
Div & Yield:
N/A (N/A%)
Add JAZZ to Portfolio
Download Data
HEADLINES
Emerging Stock Report Initiates Independent Research Coverage on Jazz Pharmaceuticals, Inc.
- GlobeNewswire - Fri, Jan 22
JAZZ PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
- EDGAR Online - Wed, Jan 20
Jazz Pharmaceuticals to Present at 2010 J.P. Morgan Healthcare Conference
- PR Newswire - Fri, Jan 8
Lightning Round OT: Tekelec, Jazz Pharma and More
- CNBC - Thu, Dec 17
Jazz Pharmaceuticals Submits New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
- PR Newswire - Tue, Dec 15
[$$] Dollar Drives the Action
- RealMoney by TheStreet.com - Thu, Dec 10
Stock Watch: InvestorSoup.com Issues Market Alert for Jazz Pharmaceuticals Inc.
- GlobeNewswire - Thu, Dec 10
Buying Strength? Don't Do It! 3 PowerRatings Stocks To Test
- TradingMarkets.com - Wed, Dec 9
Coverage initiated on Jazz Pharma by Jefferies & Co
- Briefing.com - Wed, Dec 9
Jazz Pharmaceuticals appoints ARCA exec as CFO
- AP - Fri, Dec 4
» More Headlines for JAZZ...
ANALYST
EPS Est (next year)
(Dec-09)
:
-0.36
EPS Est (in 2 years)
(Dec-10)
:
0.39
Avg Rec (current)*:
2.5
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion
» Estimates
BUSINESS SUMMARY
Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States.
» Full Company Profile